Calendar TaiMed Biologics Inc.

Equities

4147

TW0004147004

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 16/07/2025			5-day change	1st Jan Change
86.00 ^TWD	+2.26%		-0.58%	0.00%

06-22	TaiMed Biologics Inc. Initiates Phase 2b Clinical Study Preparation of Bi-Monthly Dosing of TMB-365/TMB-380 Combination for the Treatment of HIV Infection	CI
06-04	TaiMed Biologics Inc. Announces Election of New Chairperson Effective June 4, 2025	CI

Chart calendar TaiMed Biologics Inc.

f51f0270249d687dbb0.0qHN0VdFkylil_L073fA-6ad45axxUn8MUN2OHoqTfY.vciVszVywEMMr7zNjgW2rODfjv7SnBifdAYVVzdjAZWn6qmZHTG-cFXSgQ~cbdd45ae9245d0eb14768e8ea704400c

Upcoming events on TaiMed Biologics Inc.

07/08/2025	Q2 2025 Earnings Release (Projected)
11/11/2025	Q3 2025 Earnings Release (Projected)
11/03/2026	Q4 2025 Earnings Release (Projected)
07/05/2026	Q1 2026 Earnings Release (Projected)

Past events on TaiMed Biologics Inc.

07/07/2025 17:00	June 2025 Sales and Revenue Release
05/06/2025 08:46	May 2025 Sales and Revenue Release
02/06/2025	Annual General Meeting
08/05/2025 08:57	Q1 2025 Earnings Release
06/05/2025 10:06	April 2025 Sales and Revenue Release
08/04/2025 08:18	March 2025 Sales and Revenue Release
26/03/2025 06:30	MasterLink Securities Bio Industry Conference
12/03/2025 07:25	Q4 2024 Earnings Release
05/03/2025 09:06	February 2025 Sales and Revenue Release
07/02/2025 07:07	January 2025 Sales and Revenue Release
06/01/2025 07:25	December 2024 Sales and Revenue Release
03/12/2024 07:38	November 2024 Sales and Revenue Release
13/11/2024 08:33	Q3 2024 Earnings Release
07/11/2024 07:00	October 2024 Sales and Revenue Release
07/10/2024 08:04	September 2024 Sales and Revenue Release
05/09/2024 09:27	August 2024 Sales and Revenue Release
14/08/2024 03:01	Q2 2024 Earnings Release
07/08/2024 09:58	Q2 2024 Sales and Revenue Release
07/07/2024	June 2024 Sales and Revenue Release
13/06/2024 02:00	QIC Taiwan Healthcare Corporate Day

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026
Net sales Million TWD	Released Forecast Spread	563 521 8.01%	492 909 -45.91%	610 610 0.03%	680	700
EBITDA Million TWD	Released Forecast Spread	-35,4 84,3 -141.99%	-10,8 305 -103.56%	-98,0 -5,00 -1859.7%	-54,0	0,00
EBIT Million TWD	Released Forecast Spread	-192 -79,2 -142.27%	-166 -29,0 -474.07%	-252 -169 -49.27%	-220	-68,0
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	-269 -108 -148.7%	-195 -13,7 -1324.54%	-202 -125 -61.47%	-217	-54,0
Net income Million TWD	Released Forecast Spread	-269 -108 -148.65%	-195 -26,4 -636.79%	-202 -125 -61.47%	-217	-54,0
EPS TWD	Released Forecast Spread	-1,07 -0,43 -148.84%	-0,77 -0,11 -592.32%	-0,75 -0,46 -63.04%	-0,79	-0,20
Announcement Date		10/03/23	20/03/24	14/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2
Net sales Million TWD	Released Forecast Spread	158 138 14.58%	158 148 7.26%	179 104 72.07%	147 133 10.9%	139 141 -1.77%	146 146 -0.16%	176 165 7.14%	164	170	182	175	161
EBITDA Million TWD	Released Forecast Spread	35,4 46,0 -23.02%	12,2 286 -95.72%	1,71 48,0 -96.45%	-2,59 76,0 -103.41%	-6,85 -5,00 -36.94%	-90,3 1,00 -9125.1%	4,97 3,00 65.73%	4,00	-21,0	-40,0
EBIT Million TWD	Released Forecast Spread	-3,29 -40,0 91.78%	-26,5 -32,0 17.19%	-37,1 -49,0 24.39%	-41,3 -38,5 -7.15%	-45,4 -46,7 2.68%	-129 -47,3 -171.58%	-33,3 -41,0 18.7%	-38,0	-68,0	-73,3	-17,0	-29,0
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	-5,88 -39,5 85.12%	-60,3 -29,5 -104.36%	-16,0 -43,0 62.7%	-27,5 -39,0 29.41%	-37,8 -46,7 19.03%	-120 -46,7 -158.16%	-25,8 -40,7 36.55%	-37,3	-67,0	-72,0	-13,0	-25,0
Net income Million TWD	Released Forecast Spread	-5,88 -39,5 85.12%	-60,3 -29,5 -104.36%	-16,0 -43,0 62.7%	-27,5 -37,0 25.59%	-37,8 -46,7 19.03%	-120 -46,7 -158.16%	-25,8 -40,7 36.55%	-37,3	-67,0	-72,0	-13,0	-25,0
EPS TWD	Released Forecast Spread	-0,02 -0,16 87.3%	-0,24 -0,12 -104.26%	-0,06 -0,17 64.71%	-0,10 -0,14 28.57%	-0,14 -0,17 17.65%	-0,44 -0,17 -158.82%	-0,09 -0,15 38.64%	-0,13	-0,24	-0,27	-0,05	-0,09
Announcement Date		14/11/23	20/03/24	14/05/24	14/08/24	13/11/24	14/03/25	12/05/25	-	-	-	-	-

Upcoming sector events for TaiMed Biologics Inc.

22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
27/07/2025	EXELIXIS, INC.: Q2 2025 Earnings Release
27/07/2025	WUXI APPTEC CO., LTD.: Q2 2025 Earnings Release
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	INSMED INCORPORATED: Q2 2025 Earnings Release (Projected)

More events

Past sector events for TaiMed Biologics Inc.

10/07/2025 12:00	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release
10/07/2025 08:10	LUMOSA THERAPEUTICS CO., LTD.: June 2025 Sales and Revenue Release
09/07/2025 21:01	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release
07/07/2025 17:00	TAIMED BIOLOGICS INC.: June 2025 Sales and Revenue Release
05/07/2025 03:24	PHARMAESSENTIA CORPORATION: June 2025 Sales and Revenue Release
12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
05/06/2025 08:46	TAIMED BIOLOGICS INC.: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release